Pharmacokinetic Studies in Infants Using Minimal-risk Study Designs

ISSN: 2212-3938 (Online)
ISSN: 1574-8847 (Print)


Volume 9, 4 Issues, 2014


Download PDF Flyer




Current Clinical Pharmacology

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Pharmacokinetic Studies in Infants Using Minimal-risk Study Designs

Author(s): J. Autmizguine, D K. Benjamin, P B. Smith, M. Sampson, P. Ovetchkine, M. Cohen-Wolkowiez and K M. Watt

Affiliation: Duke Clinical Research Institute Duke University Medical Center Durham, NC USA

Abstract

Infants are therapeutic orphans. Many drugs used in infantsare used “off-label”, increasing the risk of drug toxicity and suboptimal efficacy in this vulnerable population. This knowledge gap in clinical pharmacology is partly attributed to challenges associatedwith conducting clinical trials in infants. Consequently, there is a need for novel and efficient study designs more suited to this population.Available literature describing the use of minimal-risk approaches to characterize the pharmacokinetics (PK) of drugs in infants was critically reviewed. Population PK approach with sparse sampling was found to be well established. Other, more recent alternatives, like dried blood spots sampling, opportunistic design, and the use of non-blood matrices are promising strategies with an increasing number of applications in infants. Physiologically based pharmacokinetic modeling provides valuable insight in drug disposition but still needs more prospective validation. Increasing experience with these methodsprovides understanding of their strengths and limitations and will help improve the design of future PK studies in infants

Keywords: Clinical trial, dried blood spots, infants, pharmacokinetics, population pharmacokinetics, scavenged sampling, sparse sampling, ultra–low-volume drug assays

Purchase Online Rights and Permissions

Article Details

Volume: 9
First Page: 1
Last Page: 9
Page Count: 9
DOI: 10.2174/1574884709666140520153308
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science